Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II Study of Vero Cell-Derived H5N1 Influenza Vaccine in Healthy Adults
NCT00349141Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- Jun 2006
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of inactivated Vero cell based whole virus influenza A/H5N1, sponsored by Resilience Government Services. Started Jun 2006; status: completed.
02
Drugs
inactivated Vero cell based whole virus influenza A/H5N1
Beyond the preview
Go deeper on NCT00349141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00349141.